SPEROKID Nasal Spray - Vietnam Registration 230000022/PCBA-LA
Access comprehensive regulatory information for SPEROKID Nasal Spray in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại A medical device is registered under number 230000022/PCBA-LA and manufactured by Pharmaceutical Company of Vietnam (Đông Dược Việt).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
230000022/PCBA-LA
000.00.17.H39-230329-0001
03/SPEROKID
Technical Details
- Enhancing natural immunity against the invasion of respiratory viruses, including flu, respiratory syncytial virus (RSV), Coronavirus, and Rhinovirus - Support for the treatment, prevention, and improvement of respiratory viral infections - Support for the regulation of reduced inflammatory response in the respiratory tract, including asthma-related inflammation - Reduction of flu symptoms (cough, fever, sore throat) - Reduction of nasal allergy symptoms - Support for enhancing the antigenic response to the Coronavirus vaccine
Dates and Status
Apr 04, 2023